ScholarlyArticle · 2026

First-Line Nivolumab Plus Ipilimumab in Inoperable Epithelioid Malignant Pleural Mesothelioma: Real-World Experience From an Indian Tertiary Care Center

Avi Shah, Ankit Agarwal, Vishva Rajpuria, Shiv Ghodasara, Jagdish Swami, Vibhav Kanth, Hiren Dangar, and Ashish Jakhetiya

5 sections · about 10 minutes · source text with editorial apparatus kept separate